✉news WorldEU Politics first seen 4 h ago, last 2 min ago, peak #14
European capital to help Colombian biotech firm produce 250 million vaccines
Original: Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines
A Colombian biotechnology company has received European investment to expand vaccine production, with plans to manufacture up to 250 million doses. The deal reflects Europe's push to strengthen global vaccine supply chains and Latin America's growing role in pharmaceutical manufacturing. Details on the investors and timelines have not yet been widely reported.
Why now: It highlights growing EU-Latin America cooperation in health manufacturing and vaccine security.
Rank over time, top of the chart is #1. 4 snapshots from 4 h ago to 2 min ago.
Evidence
- Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines · ColombiaOne.com
API: https://socialmediatrends-api.osmike.com/v1/trends/38631